{"nct_id":"NCT01617668","title":"A Randomized, Phase 2, Neoadjuvant Study of Weekly Paclitaxel With or Without LCL161 in Patients With Triple Negative Breast Cancer","status":"COMPLETED","status_verified_date":"2016-08","start_date":"2012-08","start_date_type":null,"primary_completion_date":"2014-09","primary_completion_date_type":"ACTUAL","completion_date":"2014-09","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["NVS"]}